Vanguard Asset Management »

Ptc Therapeutics I shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.4M 65k 68.13

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Ptc Therapeutics I

BlackRock
Vanguard Group
Rtw Investments
Henderson Group
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Vanguard Capital Management
Toronto-Dominion Bank
Armistice Capital
Geode Capital Management
Bank of America Corporation
FMR
D. E. Shaw & Co
Tang Capital Management

View all funds holding Ptc Therapeutics I